Stromal inflammation, necrosis and HER2 overexpression in ductal carcinoma in situ of the breast: another causality dilemma?

Van Bockstal, M; Libbrecht, L; Floris, G; Lambein, K; Pinder, S

Van Bockstal, M; Libbrecht, L; Floris, G; Lambein, K; Pinder, S.

Afiliación

Van Bockstal M; Department of Pathology, Ghent University Hospital, Ghent.
Libbrecht L; Department of Medical and Forensic Pathology & Cancer Research Institute Ghent (CRIG), Ghent University, Ghent.
Floris G; Department of Pathology, University Clinics Saint Luc, Brussels.
Lambein K; Laboratory of Translational Cell & Tissue Research, Department of Imaging and Pathology, University of Leuven, Leuven.
Pinder S; Department of Pathology, University Hospitals Leuven, Leuven.

Ann Oncol ; 28(9): 2317, 2017 09 01.

Article en En | MEDLINE | ID: mdl-28911076

Asunto(s)

Carcinoma Ductal de Mama; Carcinoma Intraductal no Infiltrante; Mama; Neoplasias de la Mama; Carcinoma in Situ; Humanos; Inmunohistoquímica; Inflamación; Receptor ErbB-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Ductal de Mama / Carcinoma Intraductal no Infiltrante Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google